Pathstone Holdings’s Prime Medicine PRME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-11,250
Closed -$22.4K 2268
2025
Q1
$22.4K Sell
11,250
-61
-0.5% -$121 ﹤0.01% 2189
2024
Q4
$33K Sell
11,311
-3,059
-21% -$8.93K ﹤0.01% 2280
2024
Q3
$55.6K Buy
+14,370
New +$55.6K ﹤0.01% 2267